D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 82 Citations 25,344 317 World Ranking 10884 National Ranking 125
Genetics D-index 80 Citations 24,439 321 World Ranking 1022 National Ranking 14

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Mutation

Peter Marynen mostly deals with Molecular biology, Genetics, Cancer research, Tyrosine kinase and Gene. His studies in Molecular biology integrate themes in fields like Syndecan 1, Heparan sulfate, Acute lymphocytic leukemia, Complementary DNA and MALT lymphoma. His study in Cancer research is interdisciplinary in nature, drawing from both Cellular differentiation, Gene rearrangement, Immunology and Acute leukemia.

His research integrates issues of Karyotype and JAK2 Gene Mutation in his study of Immunology. His work deals with themes such as Receptor tyrosine kinase and Imatinib mesylate, which intersect with Tyrosine kinase. Within one scientific family, Peter Marynen focuses on topics pertaining to Lymphoma under Gene, and may sometimes address concerns connected to Nucleic acid thermodynamics.

His most cited work include:

  • Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. (2498 citations)
  • Gene prioritization through genomic data fusion. (756 citations)
  • Allele-specific copy number analysis of tumors (699 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Genetics, Molecular biology, Cancer research, Gene and Chromosomal translocation. His Molecular biology research is multidisciplinary, incorporating perspectives in Fusion gene, Complementary DNA, Peptide sequence, Cytogenetics and Fluorescence in situ hybridization. His Fluorescence in situ hybridization research integrates issues from Gene rearrangement, Chromosome 12 and Pathology.

His Cancer research research includes themes of Immunology and Tyrosine kinase, ABL. Peter Marynen has included themes like Imatinib and Receptor tyrosine kinase in his Tyrosine kinase study. His studies deal with areas such as Myeloid, Acute lymphocytic leukemia and Lymphoma as well as Chromosomal translocation.

He most often published in these fields:

  • Genetics (41.19%)
  • Molecular biology (41.19%)
  • Cancer research (22.16%)

What were the highlights of his more recent work (between 2007-2018)?

  • Genetics (41.19%)
  • Cancer research (22.16%)
  • Gene (20.45%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Genetics, Cancer research, Gene, Gene duplication and Cell biology. His Cancer research research includes elements of Tyrosine kinase and PDGFRA. Peter Marynen interconnects Gene rearrangement, Breakpoint, Non-allelic homologous recombination, Comparative genomic hybridization and Hypopituitarism in the investigation of issues within Gene duplication.

His study looks at the intersection of Comparative genomic hybridization and topics like B-cell lymphoma with Chromosomal translocation. His studies examine the connections between Phenotype and genetics, as well as such issues in Ubiquitin ligase, with regards to Molecular biology, Proteasome, Drosophila melanogaster and Wnt signaling pathway. The Molecular biology study combines topics in areas such as Cleavage factor, Signal transduction and IκBα.

Between 2007 and 2018, his most popular works were:

  • Allele-specific copy number analysis of tumors (699 citations)
  • Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation (223 citations)
  • A20 Negatively Regulates T Cell Receptor Signaling to NF-κB by Cleaving Malt1 Ubiquitin Chains (180 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Mutation

Peter Marynen mainly focuses on Cancer research, Genetics, Gene duplication, Dasatinib and PDGFRA. His Cancer research research incorporates themes from Tyrosine kinase, Cellular differentiation, Immunology and Kinase activity. His Tyrosine kinase research is multidisciplinary, relying on both Fusion protein and Lymphoma.

His Immunology research incorporates elements of Internal medicine, Chemotherapy and Chromosomal translocation. His work carried out in the field of Gene duplication brings together such families of science as Molecular biology, Gene rearrangement and Comparative genomic hybridization. The study incorporates disciplines such as X-linked intellectual disability, Ubiquitin ligase and Point mutation in addition to Molecular biology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Ross L. Levine;Ross L. Levine;Martha Wadleigh;Jan Cools;Benjamin L. Ebert;Benjamin L. Ebert.
Cancer Cell (2005)

3564 Citations

Gene prioritization through genomic data fusion.

Stein Aerts;Diether Lambrechts;Sunit Maity;Peter Van Loo.
Nature Biotechnology (2006)

1066 Citations

Allele-specific copy number analysis of tumors

Peter Van Loo;Silje H. Nordgard;Silje H. Nordgard;Ole Christian Lingjærde;Hege G. Russnes.
Proceedings of the National Academy of Sciences of the United States of America (2010)

1010 Citations

The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas

Judith Dierlamm;Mathijs Baens;Iwona Wlodarska;Margarita Stefanova-Ouzounova.
Blood (1999)

997 Citations

Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males.

Hilde Van Esch;Marijke Bauters;Jaakko Ignatius;Mieke Jansen.
American Journal of Human Genetics (2005)

641 Citations

Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia

Pieter Peeters;Sophie D. Raynaud;Jan Cools;Iwona Wlodarska.
Blood (1997)

605 Citations

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

Maria Debiec-Rychter;Jan Cools;Herlinde Dumez;Raf Sciot.
Gastroenterology (2005)

560 Citations

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

C Graux;Jan Cools;C Melotte;H Quentmeier.
Nature Genetics (2004)

488 Citations

A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation

A. Carrie;L. Jun;T. Bienvenu;M.C. Vinet.
Nature Genetics (1999)

404 Citations

Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts.

G David;V Lories;B Decock;P Marynen.
Journal of Cell Biology (1990)

390 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter Marynen

Ross L. Levine

Ross L. Levine

Memorial Sloan Kettering Cancer Center

Publications: 113

Peter J. Campbell

Peter J. Campbell

Wellcome Sanger Institute

Publications: 113

Srdan Verstovsek

Srdan Verstovsek

The University of Texas MD Anderson Cancer Center

Publications: 110

Peter Van Loo

Peter Van Loo

The Francis Crick Institute

Publications: 110

Ayalew Tefferi

Ayalew Tefferi

Mayo Clinic

Publications: 109

Nicholas C.P. Cross

Nicholas C.P. Cross

University of Southampton

Publications: 89

Jan Cools

Jan Cools

KU Leuven

Publications: 81

Stefan N. Constantinescu

Stefan N. Constantinescu

Ludwig Cancer Research

Publications: 80

D. Gary Gilliland

D. Gary Gilliland

Fred Hutchinson Cancer Research Center

Publications: 79

Ruben A. Mesa

Ruben A. Mesa

The University of Texas Health Science Center at San Antonio

Publications: 79

Joris Vermeesch

Joris Vermeesch

KU Leuven

Publications: 71

Alessandro M. Vannucchi

Alessandro M. Vannucchi

University of Florence

Publications: 69

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 69

Jozef Gecz

Jozef Gecz

University of Adelaide

Publications: 66

David C. Wedge

David C. Wedge

University of Manchester

Publications: 62

James R. Lupski

James R. Lupski

Baylor College of Medicine

Publications: 61

Trending Scientists

Michael A. Bender

Michael A. Bender

Stony Brook University

Uwe Schöning

Uwe Schöning

University of Ulm

Jeffrey P. Carpenter

Jeffrey P. Carpenter

Middlebury College

Ben Green

Ben Green

University of Oxford

Rui Q. Yang

Rui Q. Yang

University of Oklahoma

Akhil Garg

Akhil Garg

Huazhong University of Science and Technology

Robert T. Kennedy

Robert T. Kennedy

University of Michigan–Ann Arbor

Tsuguo Fukuda

Tsuguo Fukuda

Tohoku University

Catherine Tomasetto

Catherine Tomasetto

Institute of Genetics and Molecular and Cellular Biology

Lutz Heide

Lutz Heide

University of Tübingen

Vittorio Erspamer

Vittorio Erspamer

Sapienza University of Rome

André Cartier

André Cartier

University of Montreal

Monica Cuskelly

Monica Cuskelly

University of Tasmania

Annie Bernier

Annie Bernier

University of Montreal

Edward Taub

Edward Taub

University of Alabama at Birmingham

Susan M. Brookhart

Susan M. Brookhart

Duquesne University

Something went wrong. Please try again later.